By Josh Beckerman

Abbott Laboratories said the U.S. Food and Drug Administration has issued Emergency Use Authorization for the company's molecular test for Covid-19.

The company is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the U.S. The tests are used on Abbott's m2000 RealTime System.

Abbott is ramping up production, with the goal of providing up to 1 million tests per week.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

March 18, 2020 18:29 ET (22:29 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbott Laboratories Charts.